Video

Examining new biological treatments in posterior uveitis

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, highlights his presentation regarding new biological treatments of posterior uveitis.

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.

See more EURETINA coverage

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
© 2025 MJH Life Sciences

All rights reserved.